Characterization of Bax-σ, a cell death-inducing isoform of Bax

Biochemical and Biophysical Research Communications

Volumn 270, Issue 3, 2000, Pages 868-879

  Schmitt, Estelle ^a   Paquet, Claudie ^a   Beauchemin, Myriam ^a   Dever Bertrand, Jessica ^a   Bertrand, Richard ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Apoptosis; Bax; Caspase; DNA damage; Mitochondria

Indexed keywords

CAMPTOTHECIN; CASPASE; CYTOCHROME C; DNA FRAGMENT; ISOPROTEIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BAX SIGMA; UNCLASSIFIED DRUG; VINBLASTINE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY;

EID: 0034696814     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2537     Document Type: Article

References (61)

1. Chao D. T., Korsmeyer S. J. Bcl-2 family - Regulators of cell death. Annu. Rev. Immunol. 16:1998;395-419.
2. Reed J. C., Jurgensmeier J. M., Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta. 1366:1998;127-137.
3. Zamzami N., Brenner C., Marzo I., Susin S. A., Kroemer G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene. 16:1998;2265-2282.
4. Krajewski S., Tanaka S., Takayama S., Schibler M. J., Fenton W., Reed J. C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:1993;4701-4714.
5. Gonzalez-Garcia M., Perez-Ballestero R., Ding L., Duan L., Boise L. H., Thompson C. B., Nunez G. bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development. 120:1994;3033-3042.
6. Zha H., Fisk H. A., Yaffe M. P., Mahajan N., Herman B., Reed J. C. Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell. Biol. 16:1996;6494-6508.
7. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
8. Apte S. S., Mattei M. G., Olsen B. R. Mapping of the human Bax gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, Baxδ Genomics. 26:1995;592-594.
9. Zhou M., Demo S. D., McClure T. N., Crea R., Bitler C. M. A novel splice variant of the cell death-promoting protein bax. J. Biol. Chem. 273:1998;11930-11936.
10. Shi B., Triebe D., Kajiji S., Iwata K. K., Bruskin A., Mahajna J. Identification and characterization of Bax epsilon, a novel Bax variant missing the BH2 and the transmembrane domains. Biochem. Biophys. Res. Commun. 254:1999;779-785.
11. Thomas A., Elrouby S., Reed J. C., Krajewski S., Silber R., Potmesil M., Newcomb E. W. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia - Relationship between p53 gene mutation and Bcl-2/Bax proteins in drug resistance. Oncogene. 12:1996;1055-1062.
12. He H. L., Hershberger P. A., McCarthy S. A. Characterization of a novel Bax-associated protein expressed in hemopoietic tissues and regulated during thymocyte apoptosis. J. Immunol. 161:1998;1169-1175.
13. Strobel T., Swanson L., Korsmeyer S., Cannistra S. A. Bax enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc. Natl. Acad. Sci. USA. 93:1996;14094-14099.
14. Hsu Y. T., Wolter K. G., Youle R. J. Cytosol-to-membrane redistribution of Bax and Bcl-X-L during apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;3668-3672.
15. Wolter K. G., Hsu Y. T., Smith C. L., Nechushtan A., Xi X. G., Youle R. J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1997;1281-1292.
16. Rosse T., Olivier R., Monney L., Rager M., Conus S., Fellay I., Jansen B., Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome C. Nature. 391:1998;496-499.
17. Gross A., Jockel J., Wei M. C., Korsmeyer S. J. Enforced dimerization of Bax results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:1998;3878-3885.
18. Xiang J. L., Chao D. T., Korsmeyer S. J. Bax-induced cell death may not require Interleukin 1-beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1996;14559-14563.
19. Bossywetzel E., Newmeyer D. D., Green D. R. Mitochondrial cytochrome C release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
20. Shimizu S., Narita M., Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature. 399:1999;483-487.
21. Muchmore S. W., Sattler M., Liang H., Meadows R. P., Harlan J. E., Yoon H. S., Nettesheim D., Chang B. S., Thompson C. B., Wong S. L., Ng S. C., Fesik S. W. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
22. Minn A. J., Velez P., Schendel S. L., Liang H., Muchmore S. W., Fesik S. W., Fill M., Thompson C. B. Bcl-xL forms an ion channel in synthetic lipid membranes. Nature. 385:1997;353-357.
23. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J. J., Mazzei G., Maundrell K., Gambale F., Sadoul R., Martinou J. C. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:1997;370-372.
24. Schendel S. L., Xie Z. H., Montal M. O., Matsuyama S., Montal M., Reed J. C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:1997;5113-5118.
25. Schlesinger P. H., Gross A., Yin X. M., Yamamoto K., Saito M., Waksman G., Korsmeyer S. J. Comparison of the ion channel characteristics of proapoptotic Bax and antiapoptotic Bcl-2. Proc. Natl. Acad. Sci. USA. 94:1997;11357-11362.
26. Marzo I., Brenner C., Zamzami N., Jurgensmeier J. M., Susin S. A., Vieira H. L. A., Prevost M. C., Xie Z. H., Matsuyama S., Reed J. C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
27. 2+ ions. J. Cell Biol. 143:1998;217-224.
28. Matsuyama S., Xu Q. L., Velours J., Reed J. C. The mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell. 1:1998;327-336.
29. Schmitt E., Cimoli G., Steyaert A., Bertrand R. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Exp. Cell Res. 240:1998;107-121.
30. Schmitt E., Steyaert A., Cimoli G., Bertrand R. Bax-α promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells. Cell Death Differ. 5:1998;506-516.
31. Kluck R. M., Bossywetzel E., Green D. R., Newmeyer D. D. The release of cytochrome C from mitochondria - A primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
32. Decaudin D., Geley S., Hirsch T., Castedo M., Marchetti P., Macho A., Kofler R., Kroemer G. Bcl-2 and Bcl-X(L) antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57:1997;62-67.
33. Susin S. A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis - Doubt no more. Biochim. Biophys. Acta. 1366:1998;151-165.
34. Vander Heiden M. G., Chandel N. S., Williamson E. K., Schumacker P. T., Thompson C. B. Bcl-X(L) regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
35. Jurgensmeier J. M., Xie Z. H., Deveraux Q., Ellerby L., Bredesen D., Reed J. C. Bax directly induces release of cytochrome C from isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95:1998;4997-5002.
36. Zou H., Henzel W. J., Liu X. S., Lutschg A., Wang X. D. Apaf-1, a human protein homologous to C. Elegans Ced-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413.
37. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
38. Srinivasula S. M., Ahmad M., Fernandes-Alnemri T., Alnemri E. S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1:1998;949-957.
39. Pastorino J. G., Chen S. T., Tafani M., Snyder J. W., Farber J. L. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273:1998;7770-7775.
40. Yang E., Korsmeyer S. J. Molecular thanatopsis - A discourse on the bcl2 family and cell death. Blood. 88:1996;386-401.
41. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
42. Schmitt E., Steyeart A., Bertrand R. Bcl-xES, a novel bcl-x-related cDNA in human cells: Potential role regulating apoptosis. Programmed Cell Death Meeting. 1995;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
43. Krajewski S., Blomqvist C., Franssila K., Krajewska M., Wasenius V. M., Niskanen E., Nordling S., Reed J. C. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55:1995;4471-4478.
44. Bargou R. C., Wagener C., Bommert K., Mapara M. Y., Daniel P. T., Arnold W., Dietel M., Guski H., Feller A., Royer H. D., Dorken B. Overexpression of the death-promoting gene Bax-Alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in Scid mice. J. Clin. Invest. 97:1996;2651-2659.
45. Sakakura C., Sweeney E. A., Shirahama T., Igarashi Y., Hakomori S., Nakatani H., Tsujimoto H., Imanishi T., Ohgaki M., Ohyama T., Yamazaki J., Hagiwara A., Yamaguchi T., Sawai K., Takahashi T. Overexpression of Bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int. J. Cancer. 67:1996;101-105.
46. Wagener C., Bargou R. C., Daniel P. T., Bommert K., Mapara M. Y., Royer H. D., Dorken B. Induction of the death-promoting gene Bax-Alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int. J. Cancer. 67:1996;138-141.
47. Chresta C. M., Masters J. R. W., Hickman J. A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax-Bcl-2 ratio. Cancer Res. 56:1996;1834-1841.
48. McConkey D. J., Chandra J., Wright S., Plunkett W., McDonnell T. J., Reed J. C., Keating M. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. J. Immunol. 156:1996;2624-2630.
49. Simonian P. L., Grillot D. A. M., Merino R., Nunez G. Bax can antagonize Bcl-X(L) during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-X(L). J. Biol. Chem. 271:1996;22764-22772.
50. Strobel T., Kraeft S. K., Chen L. B., Cannistra S. A. Bax expression is associated with enhanced intracellular accumulation of paclitaxel - A novel role for Bax during chemotherapy-induced cell death. Cancer Res. 58:1998;4776-4781.
51. Bertrand R., Sarang M., Jenkin J., Kerrigan D., Pommier Y. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res. 51:1991;6280-6285.
52. Hsu S. Y., Kaipia A., McGee E., Lomeli M., Hsueh A. J. W. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl. Acad. Sci. USA. 94:1997;12401-12406.
53. Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B., Korsmeyer S. J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
54. Boyd J. M., Gallo G. J., Elangovan B., Houghton A. B., Malstrom S., Avery B. J., Ebb R. G., Subramanian T., Chittenden T., Lutz R. J., Chinnadurai G. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 11:1995;1921-1928.
55. D'Sa-Eipper C., Subramanian T., Chinnadurai G. Bfl-1, a Bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res. 56:1996;3879-3882.
56. Chittenden T., Harrington E. A., O'Connor R., Flemington C., Lutz R. J., Evan G. I., Guild B. C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 374:1995;733-736.
57. Schmitt E., Sane A. T., Steyeart A., Cimoli G., Bertrand R. The Bcl-xL and Bax control points: Modulation of cancer chemotherapy-induced apoptosis and relation to TPCK-sensitive protease and caspase activation. Biochem. Cell. Biol. 75:1997;301-314.
58. Bertrand R., Pommier Y. Assessment of DNA damage in mammalian cells by DNA filter elution methodology. Studzinski G. P. Cell Growth and Apoptosis: A Practical Approach. 1995;97-118 IRL Press, New York.
59. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
60. Sané A. T., Bertrand R. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-l-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res. 58:1998;3066-3072.
61. Bertrand R., Solary E., Jenkins J., Pommier Y. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp. Cell Res. 207:1993;388-397.